hnRNP B1 Inhibitors
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are a family of RNA-binding proteins that play critical roles in the regulation of RNA metabolism, including splicing, stability, and transport. hnRNP B1 is a member of this family and is involved in pre-mRNA processing as well as other aspects of RNA biology. Inhibitors targeting hnRNP B1 are small molecules or biologics designed to modulate the function of this protein by interfering with its RNA-binding activity, protein-protein interactions, or its role in post-transcriptional gene regulation. These inhibitors are typically developed through rational drug design, based on the structure of hnRNP B1, and can be either selective or non-selective in their action against various hnRNP family members.
hnRNP B1 inhibitors can interact with the protein by binding to key regions essential for its function, such as RNA recognition motifs (RRMs) or other domains responsible for its role in mRNA splicing and transport. Through these interactions, inhibitors can alter the ability of hnRNP B1 to regulate specific gene expression patterns by influencing alternative splicing or RNA stabilization. Some inhibitors may target the structural conformation of hnRNP B1, thereby disrupting its interaction with other proteins or RNA molecules. This chemical class is important for studying the fundamental biological processes regulated by hnRNP B1, offering insights into its molecular mechanisms and downstream effects on gene expression and cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates DNA and by doing so, can obstruct the transcriptional machinery, leading to a reduction in the transcription levels of genes such as hnRNP B1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA at the transcription initiation complex and blocks RNA polymerase progression, which could decrease the synthesis of hnRNP B1 mRNA. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A preferentially binds to G-C rich DNA sequences, potentially downregulating hnRNP B1 expression by hindering the binding of transcription factors necessary for its transcription. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone binds to DNA and inhibits topoisomerase II, leading to DNA breaks and potentially diminishing the expression of hnRNP B1 by disrupting its gene transcription. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine, through its intercalation into DNA, can inhibit the transcriptional process and consequently reduce the level of hnRNP B1 expression by preventing RNA polymerase from functioning. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, leading to the prevention of DNA relegation during transcription, which could lead to the downregulation of hnRNP B1 mRNA synthesis. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide blocks the initiation of protein translation, which could lead to a decrease in hnRNP B1 protein levels by preventing its mRNA from being translated. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Silvestrol disrupts the initiation stage of protein translation, specifically reducing the synthesis of hnRNP B1 by blocking the recruitment of the 40S ribosomal subunit to the mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin strongly inhibits RNA polymerase II activity, thus could sharply decrease the transcription of hnRNP B1 mRNA, leading to reduced protein synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide directly inhibits RNA polymerase II-mediated transcription, which would result in a significant reduction in hnRNP B1 mRNA levels and consequently its protein abundance. | ||||||